A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults (Q99518852)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults |
clinical trial |
Statements
A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV (English)
0 references
17 August 2020
0 references
November 2021
0 references
2,904
0 references